Royal Bank Of Canada Moderna, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Moderna, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 629,967 shares of MRNA stock, worth $23.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

629,967

Previous 637,325 1.15%

Holding current value

$23.2 Million

Previous $75.7 Million 44.37%

% of portfolio

0.01%

Previous 0.02%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$63.64 - $125.14 $468,263 - $920,780	-7,358 Reduced 1.15%	629,967 $42.1 Million
Q2 2024 Nov 06, 2024	SELL	$101.21 - $166.61 $325,997 - $536,650	-3,221 Reduced 0.5%	637,325 $75.7 Million
Q2 2024 Aug 14, 2024	SELL	$101.21 - $166.61 $2.17 Million - $3.58 Million	-21,471 Reduced 3.24%	640,546 $76.1 Million
Q1 2024 Nov 05, 2024	BUY	$85.37 - $115.44 $1.51 Million - $2.04 Million	17,699 Added 2.76%	658,245 $70.1 Million
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $5.58 Million - $7.54 Million	-65,342 Reduced 8.98%	662,017 $70.5 Million
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $12.5 Million - $18.8 Million	179,759 Added 32.83%	727,359 $72.3 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $3.17 Million - $4.17 Million	32,902 Added 6.39%	547,600 $56.6 Million
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $10.8 Million - $14.6 Million	90,973 Added 21.47%	514,698 $62.5 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $36.8 Million - $53.5 Million	-271,588 Reduced 39.06%	423,725 $65.1 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $26.7 Million - $47.4 Million	225,528 Added 48.01%	695,313 $125 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $8.94 Million - $14.7 Million	75,684 Added 19.2%	469,785 $55.6 Million
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $1.38 Million - $2.08 Million	11,769 Added 3.08%	394,101 $56.3 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $36.8 Million - $68.5 Million	-291,308 Reduced 43.24%	382,332 $65.9 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $65.5 Million - $107 Million	290,055 Added 75.62%	673,640 $171 Million
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $22.1 Million - $48.2 Million	99,433 Added 34.99%	383,585 $148 Million
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $36.9 Million - $66.8 Million	284,152 New	284,152 $66.8 Million

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Moderna, Inc. Transaction History